The New Frontier in Male Health: AI and Sperm as a Biomarker
summary
Claims that AI reduces subjectivity in embryo grading with 84% consistency vs 52–58% for humans, that an AI+hardware system finds ICSI-viable sperm in many previously discarded micro-TESE samples and locates rare sperm in under 18 minutes, and that a low-cost optical attachment (material cost <$5) plus computer vision classifies motility and concentration and resolves morphology and DNA fragmentation. A reusable at-home device is built for longitudinal tracking and early clinical-grade screening.
AI-written summary · about
chapters (8)
- 0:00AI and male reproductive health
- 3:30AI in fertility clinics
- 8:48AI for sperm extraction
- 10:15Automated semen analysis
- 12:46Semen quality as health biomarker
- 14:36Why sperm is a health metric
- 17:27Seedbox AI-driven tracking
- 19:16Call to action for male health
related talks
21mFighting Cancer with AI
30mAIMED: AI for Prostate Cancer Detection and Immunotherapy Response
17mAI Innovation in Health
13mAI-Powered Clinical Trials
37mAI in medicine: where do we stand?
22mThe Future of AI and Digitally Enabled Health & Medicine: What's Next
44mAI in the Clinic: Prediction is Better Than Cure
12mNew Approach of Artificial Intelligence for Fertility Treatment